
Keywords: AJCC; American Joint Committee on Cancer; CBD; common bile duct; CC; cholangiocarcinoma; CMS; covered metal stent; dCC; distal cholangiocarcinoma; FRL; future remnant liver; GBA; gallbladder adenocarcinoma; iCC; intrahepatic cholangiocarcinoma; MBT; malig